Psyence Biomedical Ltd. PBM
Set alert
At close · Oct 30
After hours · Oct 30, 4:23 PM ET
- YTD
- -88.75%
- 1 year
- -97.29%
- Open
- 3.53
- Prev close
- 3.61
- Mkt cap
- 12.63M
- Vol
- 46.64K
- Avg vol
- 77.78K
- EPS
- -12.56
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.28
- High
- 3.64
- Forward P/E
- 0.00
- Beta
- -0.42
- Short ratio
- 0.08
- Inst. own
- 37.09%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.68
- 200-d avg
- 36.44
- 1y target
- 0.00
5D chart
Signals (29)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 4:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:55 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:55 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:20 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:05 PM | 2 days ago |
| SMA: Bullish | Oct 30, 11:40 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:55 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:45 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:45 AM | 2 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 3 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:45 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:15 PM | 3 days ago |
| RSI: Overbought | Oct 29, 10:35 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 11:40 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:40 AM | 4 days ago |
| SMA: Bullish | Oct 27, 3:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:20 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 11:00 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:50 AM | 5 days ago |
| RSI: Oversold | Oct 27, 9:55 AM | 5 days ago |
News
2 days ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) shares increased by 12.0% to $2.98 during Friday's pre-market session. The market value of their outstanding shares is at $115.1 million. Intensity…
-
1 week ago benzinga.com
Psyence Biomedical Completes Its Additional Investment In PsyLabs Of $2,599,896
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company") today announced that both milestones attached to its backstop subscription commitment in Psyence Labs Ltd. ("PsyLabs")
1 week ago globenewswire.com
Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met
NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today announced that both milestones attached to its backstop subscription…
-
3 weeks ago benzinga.com
Psyence Biomedical Signs Manufacturing Services Agreement With DEA-Registered Benuvia For Planned U.S. Manufacture Of Pharmaceutical-Grade Ibogaine Active Pharmaceutical Ingredient
Benuvia operates an 83,000-square-foot, DEA-registered controlled-substance manufacturing facility in Round Rock, Texas, with capabilities spanning development through commercial-scale…
3 weeks ago globenewswire.com
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
Partnership intended to establish a Texas-based manufacturing pathway for pharmaceutical-grade ibogaine as TIRC advances its planned U.S. development program Partnership intended to establish a…
-
1 month ago benzinga.com
Psyence Biomedical Unit TIRC Signs Binding Term Sheet With Psyence Labs For An Exclusive License, Supply And Wholesale Distribution Arrangement For Psylabs’ Pharmaceutical-Grade Ibogaine In The U.S.
The term sheet is binding on the parties and is to be superseded by a definitive agreement, which the parties have agreed to conclude on or before November 30, 2026; if a definitive agreement is not…
1 month ago globenewswire.com
Psyence BioMed Announces Exclusive U.S. Ibogaine Licence for Texas Ibogaine Research Corporation
Binding term sheet with PsyLabs provides Psyence BioMed's Texas subsidiary with exclusive U.S. development, supply and distribution rights to PsyLabs' pharmaceutical-grade ibogaine, subject to a…
-
1 month ago benzinga.com
Psyence Biomedical Agrees To Make Cash Investment Of Up To $5M In Psyence Labs
Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 million value-matched share exchangeHighlightsThe Company is actively advancing plans for a potential…
1 month ago globenewswire.com
Psyence BioMed Announces Strategic Ibogaine Investment
Transactions include an investment of up to US$5 million in PsyLabs and an approximately US$9 million value-matched share exchange Highlights The Company is actively advancing plans for a potential…
1 month ago globenewswire.com
Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
HIGHLIGHTS Texas-based company established as dedicated U.S. vehicle for regulated ibogaine development Positioned to hold U.S. rights to PsyLabs' pharmaceutical-grade ibogaine, subject to completion…
1 month ago benzinga.com
Modular Medical Secures National PBM Contract For Pivot Insulin Pump
Commercial-stage medical device manufacturer Modular Medical Inc. (NASDAQ:MODD) recently signed a significant contract with a national U.S. pharmacy benefit manager (PBM).
2 months ago globenewswire.com
Psyence BioMed Welcomes U.S. Administration's Latest Action to Accelerate Ibogaine Development
Company says growing federal commitment to ibogaine aligns directly with the pharmaceutical development and manufacturing platform Psyence BioMed has built Company says growing federal commitment to…
-
2 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Amylyx Pharmaceuticals (NASDAQ:AMLX) stock increased by 27.5% to $27.32 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.3 billion. bioAffinity…
4 months ago businesswire.com
Tredium Solutions Selected to Support Scripius' Pharmacy Benefits Platform
MINNEAPOLIS--(BUSINESS WIRE)--Tredium Solutions, a provider of pharmacy benefit management (PBM) technologies, has been selected to support the administration of Scripius' commercial, Medicare, and…
5 months ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
-
5 months ago benzinga.com
Psyence BioMed Establishes Active Ibogaine Operations, Production Capabilities In Africa
Psyence BioMed Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company focused on the development and supply of nature-derived psychedelic compounds for clinical research…
5 months ago globenewswire.com
Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived…
5 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
5 months ago benzinga.com
Prestige Consumer Healthcare Announces agreement To Acquire LaCorium Health, A Leader In Australian Therapeutic Skin Care For ~150M
LaCorium AcquisitionThe Company today is also announcing a definitive agreement to acquire LaCorium Health ("LaCorium"), for approximately $150 million in cash. The transaction, subject to customary…
6 months ago newsfilecorp.com
Pacific Bay Adopts Semi-Annual Reporting
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - Pacific Bay Minerals Ltd. (TSXV: PBM) ("Pacific Bay" or the "Company") reports that the Company is adopting semi-annual financial…
6 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
6 months ago benzinga.com
FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
https://www.hhs.gov/press-room/fda-accelerates-action-treatments-serious-mental-illness-following-executive-order.html
6 months ago globenewswire.com
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder
Dosing initiates clinical evaluation of NPX-5, a GMP-compliant, nature-derived psilocybin candidate across an expanded Australian site network Dosing initiates clinical evaluation of NPX-5, a…
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
6 months ago benzinga.com
Why Is Psyence Biomedical Stock Falling Wednesday?
Psyence Biomedical faces a double-digit decline Tuesday as traders lock in gains following a massive 250% speculative rally last Thursday.
6 months ago benzinga.com
Why Is Psyence Biomedical Stock Trading Lower On Tuesday?
Psyence Biomedical stock faces profit-taking on Tuesday after a massive rally fueled by a Trump executive order and news on ibogaine supply.
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
6 months ago feeds.benzinga.com
PBM Jumps On Trump Psychedelic Push, Ibogaine Supply Story
Psyence Biomedical (NASDAQ: PBM) stock is surging Monday on a broad psychedelic rally and a company-specific ibogaine supply catalyst.
6 months ago benzinga.com
PBM Jumps On Trump Psychedelic Push, Ibogaine Supply Story
Psyence Biomedical (NASDAQ: PBM) stock is surging Monday on a broad psychedelic rally and a company-specific ibogaine supply catalyst.
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
-
6 months ago benzinga.com
Psyence BioMed Builds Supply Pipeline For Psychedelic Drug Ibogaine As Demand Grows, Secures GMP-Grade Ibogaine Inventory To Support Research And Future Treatments
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a clinical-stage biopharmaceutical company advancing nature-derived psychedelic therapies and manufacturing…
6 months ago globenewswire.com
Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence BioMed" or the "Company"), a clinical-stage biopharmaceutical company advancing nature-derived psychedelic…
6 months ago benzinga.com
Why TopBuild Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $17 billion. Shares jump 20.2% to $493.01.
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
6 months ago benzinga.com
10 Health Care Stocks Moving In Friday's Intraday Session
10 Health Care Stocks Moving In Friday's Intraday Session
6 months ago benzinga.com
Dow Jumps Over 600 Points; Netflix Shares Tumble After Q1 Results
US stocks rise, Dow gains 600 points. NASDAQ up 1.05% and S&P 500 up 0.74%. Energy stocks down 4.5%. Netflix shares dip 11% on weak forecast.
-
6 months ago benzinga.com
Psyence BioMed Acknowledges U.S. Executive Order Plans To Evaluate Ibogaine's Therapeutic Potential
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a clinical-stage biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies, today acknowledged…
6 months ago globenewswire.com
Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine
Company highlights global leadership in GMP ibogaine manufacturing and commitment to ethically sourced supply Company highlights global leadership in GMP ibogaine manufacturing and commitment to…
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
6 months ago benzinga.com
Why Blaize Holdings Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket
Blaize Holdings rose 24.3% in pre-market trading on $50M contract with NeoTensr & MOU with Winmate for edge AI deployments. Other gainers & losers.
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
6 months ago benzinga.com
'Trump To Sign Executive Order On Psychedelic Drug Used Abroad To Treat PTSD' - CBS News Exclusive
https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/
6 months ago thenewswire.com
Aurwest Resources Announces Execution of Definitive Agreement on Weaver Lake Gold Project
Calgary, Alberta – TheNewswire - April 14, 2026 – Aurwest Resources Corporation (“ Aurwest ” or the “ Company ”) ( CSE: AWR ) is pleased to announce that the Company has entered into a Definitive…
-
6 months ago benzinga.com
Psyence BioMed Expands Australian Clinical Network To 5 Sites For Psilocybin Phase IIb Trial
syence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today…
6 months ago globenewswire.com
Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine…
7 months ago defenseworld.net
Head-To-Head Comparison: XBiotech (NASDAQ:XBIT) and Psyence Biomedical (NASDAQ:PBM)
Psyence Biomedical (NASDAQ: PBM - Get Free Report) and XBiotech (NASDAQ: XBIT - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies…
7 months ago globenewswire.com
Corporate Update: Psyence BioMed Advances Vertically Integrated Pharmaceutical Platform Following PsyLabs Export Milestone
“The strongest companies are built on the right foundations long before their moment arrives,” says CEO Jody Aufrichtig “The strongest companies are built on the right foundations long before their…